Literature DB >> 31447222

Paving the way for T cell-based immunotherapies in chronic hepatitis E.

Christoph Neumann-Haefelin1.   

Abstract

Entities:  

Keywords:  HEV; Immunopathology; Immunotherapy; TCR-redirected T cell; Viral persistence

Mesh：

Substances：

Year:  2019        PMID： 31447222     DOI： 10.1016/j.jhep.2019.07.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

1.  Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria.

Authors:  Elitsa Golkocheva-Markova; Ani Kevorkyan; Ralitsa Raycheva; Chiydem Ismailova; Viliana Yoncheva; Tencho Tenev; Radoslava Emilova; Lyubomira Grigorova; Ivan Baltadzhiev; Radka Komitova
Journal:  Braz J Infect Dis       Date:  2022-02-15       Impact factor: 3.257

2.  Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E.

Authors:  Marten Schulz; Paula Biedermann; Claus-Thomas Bock; Jörg Hofmann; Mira Choi; Frank Tacke; Leif Gunnar Hanitsch; Tobias Mueller
Journal:  Int J Environ Res Public Health       Date:  2020-01-03       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.